Ethnic minorities and coronary heart disease: An update and future directions

Current Atherosclerosis Reports

Volumn 18, Issue 2, 2016, Pages

  Adam Leigh, J ^a   Alvarez, Manrique ^a   Rodriguez, Carlos J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Acute coronary syndrome; Angina; CABG; Coronary heart disease; Disparity; PCI; Race and ethnicity

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; TICAGRELOR; CALCIUM;

ACUTE CORONARY SYNDROME; AFRICAN AMERICAN; ANGINA PECTORIS; ARTICLE; ASIAN; ASIAN AMERICAN; BARE METAL STENT; CARDIOVASCULAR RISK; CAUCASIAN; CLINICAL TRIAL (TOPIC); CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; ETHNIC DIFFERENCE; GENETIC DIFFERENCE; HEART INFARCTION; HISPANIC; HUMAN; ISCHEMIC HEART DISEASE; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; THROMBOCYTE AGGREGATION; CORONARY DISEASE; ETHNOLOGY; METABOLISM; RISK FACTOR;

CALCIUM; CORONARY ARTERY BYPASS; CORONARY DISEASE; HUMANS; PLATELET AGGREGATION; RISK FACTORS;

EID: 85008490300     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-016-0559-4     Document Type: Article

References (80)

1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131:e29-322.
2. Chan PS. The gap in current disparities research a lesson from the community. Circ Cardiovasc Qual Outcomes. 2014;7:785-6.
3. Bureau UC. Millennials outnumber baby boomers and are far more diverse [internet]. Available from: http://www.census.gov/newsroom/press-releases/2015/cb15-113.html?intcmp=sldr2.
4. Sardar M, Badri M, Prince CT, Seltzer J, Kowey PR. Underrepresentation of women, elderly patients, and racial minorities in the randomized trials used for cardiovascular guidelines. JAMA Intern Med. 2014;174:1868-70.
5. Census.gov [Internet]. [cited 2015 Jul 16]. Available from: http://www.census.gov/.
6. Bureau UC. New census bureau report analyzes U.S. population projections [internet]. [cited 2015 Sep 12]. Available from: http://www.census.gov/newsroom/press-releases/2015/cb15-tps16.html.
7. CDC - Hispanic - Latino - populations - racial - ethnic - minorities -minority health [internet]. [cited 2015 Jul 16]. Available from: http://www.cdc.gov/minorityhealth/populations/REMP/hispanic.html#10.
8. Liao Y, Cooper RS, Cao G, Kaufman JS, Long AE, McGee DL. Mortality from coronary heart disease and cardiovascular disease among adult U.S. Hispanics: findings from the National Health Interview Survey (1986 to 1994). J Am Coll Cardiol. 1997;30: 1200-5.
9. Rodriguez CJ, Allison M, Daviglus ML, Isasi CR, Keller C, Leira EC, et al. Status of cardiovascular disease and stroke in Hispanics/ Latinos in the United States: a science advisory from the American Heart Association. Circulation. 2014;130:593-625.
10. Sorlie PD, Avilés-Santa LM, Wassertheil-Smoller S, Kaplan RC, Daviglus ML, Giachello AL, et al. Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol. 2010;20:629-41.
11. Sempos CT, Bild DE, Manolio TA. Overview of the Jackson Heart Study: a study of cardiovascular diseases in African American men and women. Am J Med Sci. 1999;317:142-6.
12. Investigators TA. The atherosclerosis risk in communit (aric) stui)y: design and objectwes. Am J Epidemiol. 1989;129:687-702.
13. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41: 1105-16.
14. Bild DE, Bluemke DA, Burke GL, Detrano R, Roux AVD, Folsom AR, et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002;156:871-81.
15. Daviglus ML, Talavera GA, Avilés-Santa M, et al. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA. 2012;308:1775-84.
16. Kurian AK, Cardarelli KM. Racial and ethnic differences in cardio- vascular disease risk factors: a systematic review. Ethn Dis. 2007;17:143-52.
17. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation. 2005;111:1233-41.
18. Jose PO, Frank ATH, Kapphahn KI, Goldstein BA, Eggleston K, Hastings KG, et al. Cardiovascular disease mortality in Asian Americans. J Am Coll Cardiol. 2014;64:2486-94.
19. Sorlie PD, Backlund E, Johnson NJ, Rogot E. Mortality by Hispanic status in the United States. JAMA. 1993;270:2464-8.
20. Cortes-Bergoderi M, Goel K, Murad MH, Allison T, Somers VK, Erwin PJ, et al. Cardiovascular mortality in Hispanics compared to non-Hispanic whites: a systematic review and meta-analysis of the Hispanic paradox. Eur J Intern Med. 2013;24:791-9.
21. Abraído-Lanza AF, Dohrenwend BP, Ng-Mak DS, Turner JB. The Latino mortality paradox: a test of the Bsalmon bias and healthy migrant hypotheses. Am J Public Health. 1999;89:1543-8.
22. Ruiz JM, Steffen P, Smith TB. Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature. Am J Public Health. 2013;103:e52-60.
23. Medina-Inojosa J, Jean N, Cortes-Bergoderi M, Lopez-Jimenez F. The Hispanic paradox in cardiovascular disease and total mortality. Prog Cardiovasc Dis. 2014;57:286-92.
24. Caleyachetty R, Echouffo-Tcheugui JB, Muennig P, Zhu W, Muntner P, Shimbo D. Association between cumulative social risk and ideal cardiovascular health in US adults: NHANES 1999-2006. Int J Cardiol. 2015;191:296-300.
25. Folsom AR, Yatsuya H, Nettleton JA, Lutsey PL, Cushman M, Rosamond WD, et al. Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol. 2011;57:1690-6.
26. Dong C, Rundek T, Wright CB, Anwar Z, Elkind MSV, Sacco RL. Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and his-panics: the northern Manhattan study. Circulation. 2012;125:2975-84.
27. Rodriguez CJ. Disparities in ideal cardiovascular health: a challenge or an opportunity? Circulation. 2012;125:2963-4.
28. Kwagyan J, Retta TM, Ketete M, Bettencourt CN, Maqbool AR, Xu S, et al. Obesity and cardiovascular diseases in a high-risk population: evidence-based approach to CHD risk reduction. Ethn Dis. 2015;25:208-13.
29. Goff DC, Bertoni AG, Kramer H, Bonds D, Blumenthal RS, Tsai MY, et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA) gender, ethnicity, and coronary artery calcium. Circulation. 2006;113:647-56.
30. Bennet A, Di Angelantonio E, Erqou S, Eiriksdottir G, Sigurdsson G, Woodward M, et al. Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data. Arch Intern Med. 2008;168:598-608.
31. Virani SS, Brautbar A, Davis BC, Nambi V, Hoogeveen RC, Sharrett AR, et al. Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2012;125:241-9.
32. Guan W, Cao J, Steffen BT, Post WS, Stein JH, Tattersall MC, et al. Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35:996-1001.
33. Daviglus ML, Pirzada A, Talavera GA. Cardiovascular disease risk factors in the Hispanic/Latino population: lessons from the Hispanic Community Health Study/Study of Latinos (HCHS/ SOL). Prog Cardiovasc Dis. 2014;57:230-6.
34. Rodriguez CJ, Cai J, Swett K, González HM, Talavera GA, Wruck LM, et al. High cholesterol awareness, treatment, and control among Hispanic/Latinos: results from the Hispanic Community Health Study/Study of Latinos. J Am Heart Assoc. 2015;4: e001867.
35. Kershaw KN, Osypuk TL, Do DP, Chavez PJD, Roux AVD. Neighborhood-level racial/ethnic residential segregation and incident cardiovascular disease the Multi-Ethnic Study of Atherosclerosis. Circulation. 2015;131:141-8.
36. NHANES - National Health and Nutrition Examination Survey Homepage [Internet]. [cited 2015 Aug 13]. Available from: http://www.cdc.gov/nchs/nhanes.htm.
37. de Souza RJ, Anand SS. Cardiovascular disease in Asian Americans: unmasking heterogeneity∗. J Am Coll Cardiol. 2014;64:2495-7.
38. Yeboah J, McClelland RL, Polonsky TS, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA. 2012;308:788-95.
39. Bild DE. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2005;111: 1313-20.
40. McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2006;113:30-7.
41. Alluri K, McEvoy JW, Dardari ZA, Jones SR, Nasir K, Blankstein R, et al. Distribution and burden of newly detected coronary artery calcium: results from the Multi-Ethnic Study of Atherosclerosis. J Cardiovasc Comput Tomogr. 2015;9:337-44.
42. Will JC, Yuan K, Ford E. National trends in the prevalence and medical history of angina: 1988 to 2012. Circ Cardiovasc Qual Outcomes. 2014;7:407-13.
43. McKee MM, Winters PC, Fiscella K. Low education as a risk factor for undiagnosed angina. J Am Board Fam Med. 2012;25:416-21.
44. Povsic TJ, Broderick S, Anstrom KJ, Shaw LK, Ohman EM, Eisenstein EL, et al. Predictors of long‐term clinical endpoints in patients with refractory angina. J Am Heart Assoc Cardiovasc Cerebrovasc Dis [Internet]. 2015, 4. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345862/.
45. Ford ES, Giles WH. Changes in prevalence of nonfatal coronary heart disease in the United States from 1971-1994. Ethn Dis. 2003;13:85-93.
46. Cohen MG, Roe MT, Mulgund J, Peterson ED, Sonel AF, Menon V, et al. Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non-ST-segment elevation acute coronary syndromes: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE). Am Heart J. 2006;152:110-7.
47. Hayes DK, Greenlund KJ, Denny CH, Neyer JR, Croft JB, Keenan NL. Racial/ethnic and socioeconomic disparities in health-related quality of life among people with coronary heart disease, 2007. Prev Chronic Dis. 2011;8:A78.
48. Deshmukh M, Joseph MA, Verdecias N, Malka ES, LaRosa JH. Acute coronary syndrome: factors affecting time to arrival in a diverse urban setting. J Community Health. 2011;36:895-902.
49. Gillespie CD, Wigington C, Hong Y, Centers for Disease Control and Prevention (CDC). Coronary heart disease and stroke deaths—United States, 2009. Morb Mortal Wkly Rep Surveill Summ. 2013;62 Suppl 3:157-60.
50. DeVon HA, Burke LA, Nelson H, Zerwic JJ, Riley B. Disparities in patients presenting to the emergency department with potential acute coronary syndrome: it matters if you are Black or White. Heart Lung J Acute Crit Care. 2014;43:270-7.
51. Movahed MR, Khan MF, Hashemzadeh M, Hashemzadeh M. Age adjusted nationwide trends in the incidence of all cause and ST elevation myocardial infarction associated cardiogenic shock based on gender and race in the United States. Cardiovasc Revasc Med. 2015;16:2-5.
52. Tataris KL, Mercer MP, Govindarajan P. Prehospital aspirin admin-istration for acute coronary syndrome (ACS) in the USA: an EMS quality assessment using the NEMSIS 2011 database. Emerg Med J EMJ 2015.
53. Mathews R, Wang TY, Honeycutt E, Henry TD, Zettler M, Chang M, et al. Persistence with secondary prevention medications after acute myocardial infarction: insights from the TRANSLATE-ACS study. Am Heart J. 2015;170:62-9.
54. Cavender MA, Rassi AN, Fonarow GC, Cannon CP, Peacock WF, Laskey WK, et al. Relationship of race/ethnicity with door-to-balloon time and mortality in patients undergoing primary percuta-neous coronary intervention for ST-elevation myocardial infarction: findings from get with the guidelines—coronary artery disease. Clin Cardiol. 2013;36:749-56.
55. Curtis JP, Herrin J, Bratzler DW, Bradley EH, Krumholz HM. Trends in race-based differences in door-to-balloon times. Arch Intern Med. 2010;170:992-3.
56. Dauerman HL, Bates ER, Kontos MC, Li S, Garvey JL, Henry TD, et al. Nationwide analysis of patients with ST-segment-elevation myocardial infarction transferred for primary percutaneous intervention findings from the American Heart Association Mission: Lifeline Program. Circ Cardiovasc Interv. 2015;8:e002450.
57. Ayanian JZ, Udvarhelyi IS, Gatsonis CA, Pashos CL, Epstein AM. Racial differences in the use of revascularization procedures after coronary angiography. JAMA. 1993;269:2642-6.
58. Whittle J, Conigliaro J, Good CB, Lofgren RP. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs Medical System. N Engl J Med. 1993;329:621-7.
59. Gaglia MA, Shavelle DM, Tun H, Bhatt J, Mehra A, Matthews RV, et al. African-American patients are less likely to receive drugeluting stents during percutaneous coronary intervention. Cardiovasc Revasc Med Mol Interv. 2014;15:214-8.
60. Batchelor WB, Ellis SG, Ormiston JA, Stone GW, Joshi AA, Wang H, et al. Racial differences in long-term outcomes after percutaneous coronary intervention with paclitaxel-eluting coronary stents. J Intervent Cardiol. 2013;26:49-57.
61. Cram P, Bayman L, Popescu I, Vaughan-Sarrazin MS. Racial disparities in revascularization rates among patients with similar insurance coverage. J Natl Med Assoc. 2009;101:1132-9.
62. Bhalla R, Yongue BG, Currie BP, Greenberg MA, Myrie-Weir J, DeFino M, et al. Improving primary percutaneous coronary intervention performance in an urban minority population using a quality improvement approach. Am J Med Qual. 2010;25:370-7.
63. Bangalore S, Gupta N, Guo Y, Feit F. Trend in the use of drug eluting stents in the United States: insight from over 8.1 million coronary interventions. Int J Cardiol. 2014;175:108-19.
64. Guzman LA, Li S, Wang TY, DaviglusML, Exaire J, Rodriguez CJ, et al. Differences in treatment patterns and outcomes between Hispanics and non-Hispanic Whites treated for ST-segment elevation myocardial infarction: results from the NCDR ACTION Registry—GWTG. J Am Coll Cardiol. 2012;59:630-1.
65. Olafiranye O, Vlachos H, Mulukutla SR, Marroquin OC, Selzer F, Kelsey SF, et al. Comparison of long-term safety and efficacy outcomes after drug-eluting and bare-metal stent use across racial groups: insights from NHLBI Dynamic Registry. Int J Cardiol. 2015;184:79-85.
66. Becker ER, Rahimi A. Disparities in race/ethnicity and gender inin-hospital mortality rates for coronary artery bypass surgery patients. J Natl Med Assoc. 2006;98:1729-39.
67. Rangrass G, Ghaferi AA, Dimick JB. Explaining racial disparities in outcomes after cardiac surgery: the role of hospital quality. JAMA Surg. 2014;149:223-7.
68. Girotti ME, Shih T, Revels S, Dimick JB. Racial disparities in readmissions and site of care for major surgery. J Am Coll Surg. 2014;218:423-30.
69. Khera R, Vaughan-Sarrazin M, Rosenthal GE, Girotra S. Racial disparities in outcomes after cardiac surgery: the role of hospital quality. Curr Cardiol Rep. 2015;17:29.
70. Pollock B, Hamman BL, Sass DM, da Graca B, Grayburn PA, Filardo G. Effect of gender and race on operative mortality after isolated coronary artery bypass grafting. Am J Cardiol. 2015;115: 614-8.
71. Tourdot BE, Conaway S, Niisuke K, Edelstein LC, Bray PF, Holinstat M. Mechanism of race-dependent platelet activation through the protease-activated receptor-4 and Gq signaling axis. Arterioscler Thromb Vasc Biol. 2014;34:2644-50.
72. Bray PF, Mathias RA, Faraday N, Yanek LR, Fallin MD, Herrera-Galeano JE, et al. Heritability of platelet function in families with premature coronary artery disease. J Thromb Haemost. 2007;5: 1617-23.
73. Edelstein LC, Simon LM, Montoya RT, Holinstat M, Chen ES, Bergeron A, et al. Racial difference in human platelet PAR4 reactivity reflects expression of PCTP and miR-376c. Nat Med [Internet]. 2013 [cited 2015 Sep 21];19. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855898/.
74. Carty CL, Keene KL, Cheng Y-C, Meschia JF, Chen W-M, Nalls M, et al. Meta-analysis of genome-wide association studies identifies genetic risk factors for stroke in African Americans. Stroke. 2015;46:2063-8.
75. Qayyum R, Becker LC, Becker DM, Faraday N, Yanek LR, Leal SM, et al. Genome-wide association study of platelet aggregation in African Americans. BMC Genet [Internet]. 2015 [cited 2015 Sep 21];16. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448541/.
76. Kang H-J, Clare RM, Gao R, Held C, Himmelmann A, James SK, et al. Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: a retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Am Heart J. 2015;169:899-905.
77. Waksman R, Maya J, Angiolillo DJ, Carlson GF, Teng R, Caplan RJ, et al. Ticagrelor versus clopidogrel in black patients with stable coronary artery disease prospective, randomized, open-label, multiple-dose, crossover pilot study. Circ Cardiovasc Interv. 2015;8: e002232.
78. Health coverage by race and ethnicity: the potential impact of the affordable care act [internet]. [cited 2015 Sep 13]. Available from: http://kff.org/disparities-policy/issue-brief/health-coverage-by-race-and-ethnicity-the-potential-impact-of-the-affordable-care-act/.
79. Health Insurance Coverage and the Affordable Care Act [Internet]. ASPE. [cited 2015 Sep 13]. Available from: http://aspe.hhs.gov/pdf-document/health-insurance-coverage-and-affordable-care-act.
80. Burke JF, Vijan S, Chekan LA, Makowiec TM, Thomas L, Morgenstern LB. Targeting high-risk employees may reduce cardiovascular racial disparities. Am J Manag Care. 2014;20:725-33.